Cargando…
Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study
BACKGROUND: SARS-CoV-2 infection can lead to multisystem inflammatory syndrome in children (MIS-C). We sought to investigate risk factors for admission to the intensive care unit (ICU) and explored changes in disease severity over time. METHODS: We obtained data from chart reviews of children younge...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001008/ https://www.ncbi.nlm.nih.gov/pubmed/35410860 http://dx.doi.org/10.1503/cmaj.210873 |
_version_ | 1784685572525129728 |
---|---|
author | Merckx, Joanna Cooke, Suzette El Tal, Tala Bitnun, Ari Morris, Shaun K. Yeh, E. Ann Yea, Carmen Gill, Peter Papenburg, Jesse Lefebvre, Marie-Astrid Scuccimarri, Rosie Ulloa-Gutierrez, Rolando Brenes-Chacon, Helena Yock-Corrales, Adriana Ivankovich-Escoto, Gabriela Soriano-Fallas, Alejandra Mezerville, Marcela Hernandez-de Dewan, Tammie Restivo, Lea Nateghian, Alireza Aski, Behzad Haghighi Manafi, Ali Dwilow, Rachel Bullard, Jared Lopez, Alison Sadarangani, Manish Roberts, Ashley Barton, Michelle Petel, Dara Le Saux, Nicole Bowes, Jennifer Purewal, Rupeena Lautermilch, Janell Tehseen, Sarah Bayliss, Ann Wong, Jacqueline K. Leifso, Kirk Foo, Cheryl Robinson, Joan |
author_facet | Merckx, Joanna Cooke, Suzette El Tal, Tala Bitnun, Ari Morris, Shaun K. Yeh, E. Ann Yea, Carmen Gill, Peter Papenburg, Jesse Lefebvre, Marie-Astrid Scuccimarri, Rosie Ulloa-Gutierrez, Rolando Brenes-Chacon, Helena Yock-Corrales, Adriana Ivankovich-Escoto, Gabriela Soriano-Fallas, Alejandra Mezerville, Marcela Hernandez-de Dewan, Tammie Restivo, Lea Nateghian, Alireza Aski, Behzad Haghighi Manafi, Ali Dwilow, Rachel Bullard, Jared Lopez, Alison Sadarangani, Manish Roberts, Ashley Barton, Michelle Petel, Dara Le Saux, Nicole Bowes, Jennifer Purewal, Rupeena Lautermilch, Janell Tehseen, Sarah Bayliss, Ann Wong, Jacqueline K. Leifso, Kirk Foo, Cheryl Robinson, Joan |
author_sort | Merckx, Joanna |
collection | PubMed |
description | BACKGROUND: SARS-CoV-2 infection can lead to multisystem inflammatory syndrome in children (MIS-C). We sought to investigate risk factors for admission to the intensive care unit (ICU) and explored changes in disease severity over time. METHODS: We obtained data from chart reviews of children younger than 18 years with confirmed or probable MIS-C who were admitted to 15 hospitals in Canada, Iran and Costa Rica between Mar. 1, 2020, and Mar. 7, 2021. Using multivariable analyses, we evaluated whether admission date and other characteristics were associated with ICU admission or cardiac involvement. RESULTS: Of 232 children with MIS-C (median age 5.8 yr), 130 (56.0%) were male and 50 (21.6%) had comorbidities. Seventy-three (31.5%) patients were admitted to the ICU but none died. We observed an increased risk of ICU admission among children aged 13–17 years (adjusted risk difference 27.7%, 95% confidence interval [CI] 8.3% to 47.2%), those aged 6–12 years (adjusted risk difference 25.2%, 95% CI 13.6% to 36.9%) or those with initial ferritin levels greater than 500 μg/L (adjusted risk difference 18.4%, 95% CI 5.6% to 31.3%). Children admitted to hospital after Oct. 31, 2020, had numerically higher rates of ICU admission (adjusted risk difference 12.3%, 95% CI −0.3% to 25.0%) and significantly higher rates of cardiac involvement (adjusted risk difference 30.9%, 95% CI 17.3% to 44.4%). At Canadian sites, the risk of ICU admission was significantly higher for children admitted to hospital between December 2020 and March 2021 than those admitted between March and May 2020 (adjusted risk difference 25.3%, 95% CI 6.5% to 44.0%). INTERPRETATION: We observed that age and higher ferritin levels were associated with more severe MIS-C. We observed greater severity of MIS-C later in the study period. Whether emerging SARS-CoV-2 variants pose different risks of severe MIS-C needs to be determined. |
format | Online Article Text |
id | pubmed-9001008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90010082022-04-15 Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study Merckx, Joanna Cooke, Suzette El Tal, Tala Bitnun, Ari Morris, Shaun K. Yeh, E. Ann Yea, Carmen Gill, Peter Papenburg, Jesse Lefebvre, Marie-Astrid Scuccimarri, Rosie Ulloa-Gutierrez, Rolando Brenes-Chacon, Helena Yock-Corrales, Adriana Ivankovich-Escoto, Gabriela Soriano-Fallas, Alejandra Mezerville, Marcela Hernandez-de Dewan, Tammie Restivo, Lea Nateghian, Alireza Aski, Behzad Haghighi Manafi, Ali Dwilow, Rachel Bullard, Jared Lopez, Alison Sadarangani, Manish Roberts, Ashley Barton, Michelle Petel, Dara Le Saux, Nicole Bowes, Jennifer Purewal, Rupeena Lautermilch, Janell Tehseen, Sarah Bayliss, Ann Wong, Jacqueline K. Leifso, Kirk Foo, Cheryl Robinson, Joan CMAJ Research BACKGROUND: SARS-CoV-2 infection can lead to multisystem inflammatory syndrome in children (MIS-C). We sought to investigate risk factors for admission to the intensive care unit (ICU) and explored changes in disease severity over time. METHODS: We obtained data from chart reviews of children younger than 18 years with confirmed or probable MIS-C who were admitted to 15 hospitals in Canada, Iran and Costa Rica between Mar. 1, 2020, and Mar. 7, 2021. Using multivariable analyses, we evaluated whether admission date and other characteristics were associated with ICU admission or cardiac involvement. RESULTS: Of 232 children with MIS-C (median age 5.8 yr), 130 (56.0%) were male and 50 (21.6%) had comorbidities. Seventy-three (31.5%) patients were admitted to the ICU but none died. We observed an increased risk of ICU admission among children aged 13–17 years (adjusted risk difference 27.7%, 95% confidence interval [CI] 8.3% to 47.2%), those aged 6–12 years (adjusted risk difference 25.2%, 95% CI 13.6% to 36.9%) or those with initial ferritin levels greater than 500 μg/L (adjusted risk difference 18.4%, 95% CI 5.6% to 31.3%). Children admitted to hospital after Oct. 31, 2020, had numerically higher rates of ICU admission (adjusted risk difference 12.3%, 95% CI −0.3% to 25.0%) and significantly higher rates of cardiac involvement (adjusted risk difference 30.9%, 95% CI 17.3% to 44.4%). At Canadian sites, the risk of ICU admission was significantly higher for children admitted to hospital between December 2020 and March 2021 than those admitted between March and May 2020 (adjusted risk difference 25.3%, 95% CI 6.5% to 44.0%). INTERPRETATION: We observed that age and higher ferritin levels were associated with more severe MIS-C. We observed greater severity of MIS-C later in the study period. Whether emerging SARS-CoV-2 variants pose different risks of severe MIS-C needs to be determined. CMA Impact Inc. 2022-04-11 2022-04-11 /pmc/articles/PMC9001008/ /pubmed/35410860 http://dx.doi.org/10.1503/cmaj.210873 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Research Merckx, Joanna Cooke, Suzette El Tal, Tala Bitnun, Ari Morris, Shaun K. Yeh, E. Ann Yea, Carmen Gill, Peter Papenburg, Jesse Lefebvre, Marie-Astrid Scuccimarri, Rosie Ulloa-Gutierrez, Rolando Brenes-Chacon, Helena Yock-Corrales, Adriana Ivankovich-Escoto, Gabriela Soriano-Fallas, Alejandra Mezerville, Marcela Hernandez-de Dewan, Tammie Restivo, Lea Nateghian, Alireza Aski, Behzad Haghighi Manafi, Ali Dwilow, Rachel Bullard, Jared Lopez, Alison Sadarangani, Manish Roberts, Ashley Barton, Michelle Petel, Dara Le Saux, Nicole Bowes, Jennifer Purewal, Rupeena Lautermilch, Janell Tehseen, Sarah Bayliss, Ann Wong, Jacqueline K. Leifso, Kirk Foo, Cheryl Robinson, Joan Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study |
title | Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study |
title_full | Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study |
title_fullStr | Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study |
title_full_unstemmed | Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study |
title_short | Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study |
title_sort | predictors of severe illness in children with multisystem inflammatory syndrome after sars-cov-2 infection: a multicentre cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001008/ https://www.ncbi.nlm.nih.gov/pubmed/35410860 http://dx.doi.org/10.1503/cmaj.210873 |
work_keys_str_mv | AT merckxjoanna predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT cookesuzette predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT eltaltala predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT bitnunari predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT morrisshaunk predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT yeheann predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT yeacarmen predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT gillpeter predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT papenburgjesse predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT lefebvremarieastrid predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT scuccimarrirosie predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT ulloagutierrezrolando predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT breneschaconhelena predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT yockcorralesadriana predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT ivankovichescotogabriela predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT sorianofallasalejandra predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT mezervillemarcelahernandezde predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT dewantammie predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT restivolea predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT nateghianalireza predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT askibehzadhaghighi predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT manafiali predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT dwilowrachel predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT bullardjared predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT lopezalison predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT sadaranganimanish predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT robertsashley predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT bartonmichelle predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT peteldara predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT lesauxnicole predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT bowesjennifer predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT purewalrupeena predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT lautermilchjanell predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT tehseensarah predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT baylissann predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT wongjacquelinek predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT leifsokirk predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT foocheryl predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy AT robinsonjoan predictorsofsevereillnessinchildrenwithmultisysteminflammatorysyndromeaftersarscov2infectionamulticentrecohortstudy |